Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Telos Rx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Telos Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 23 · Grade B

Telos Rx

Visit Telos Rx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 85 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Telos Rx a bad call — it's best for people considering different treatment formats with a clinician and willing to obtain a complete written quote. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
84
Supply Reliability
95
84
Transparency
90
79
Access Breadth
93
96
Clinical Oversight
92
85
Track Record
88
82
CoreAge RxBrief Score 94 · 85Telos Rx

Price, coverage & the tracker

CoreAge RxTelos Rx
Brief Score94/100 (A)85/100 (B)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $99/mo injectable — a floor, not a rate: Telos publishes "as low as $99" and says the price depends on plan length, which is shown only inside the intake

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $139/mo injectable · from $116/mo microdosed (microdosing is tirzepatide, not semaglutide) · the needle-free option is one "Oral GLP-1" product covering either molecule, priced from $9 a day on a 3-month prepay

CoverageUS only; restrictions by state, confirmed at intakeNot publicly listed
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Telos Rx: injectable semaglutide and tirzepatide are advertised as low as $99/$139; these are starting figures, not verified standing rates. Oral pricing on the comparison page is from $9/day.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.